Roger S. McIntyre, MD, FRCPC
|
Roger S. McIntyre, MD, FRCPC, is an Associate Professor of Psychiatry and Pharmacology
at the
University of Toronto, Ontario, Canada, and Head of the Mood Disorders Psychopharmacology
Unit
at the University Health Network, Toronto. He received his medical degree from Dalhousie
University, Halifax, Nova Scotia, Canada, and completed his psychiatry residency
training and fellowship in psychiatric pharmacology at the University of Toronto.
Dr McIntyre is involved in multiple research endeavors designed to characterize
the association between mood disorders and medical comorbidity. This research involves
elucidating metabolic adverse events associated with the use of psychotropic medications,
the impact of medical comorbidity on the course of mood disorders, and the effect
of glucose homeostasis on neurocognition.
Dr McIntyre is extensively involved in medical education. He is a highly sought-after
speaker at both national and international meetings. He has received several teaching
awards from the University of Toronto, Department of Psychiatry, and has been a
recipient of the joint Canadian Psychiatric Association (CPA)/Council of Psychiatric
Continuing Education Award for the Most Outstanding Continuing Education Activity
in Psychiatry in Canada.
Dr McIntyre is a contributor to the CPA guidelines for the treatment of depressive
disorders and the Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines
for the management of bipolar disorder. He has published extensively in leading
peer-reviewed journals and textbooks.
Dr McIntyre is also a reviewer for many journals, including the American Journal
of Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry,
and the New England Journal of Medicine.
In addition, he serves as a grant reviewer for the National Institute of Mental
Health.
|
Andrea Fagiolini, MD
|
Andrea Fagiolini, MD, is Associate Professor in the Department of Psychiatry at
the University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania, where
he is also Medical Director of the Bipolar Disorder Center and of the Depression
and Manic Depression Prevention Program, and Director of the PG-Y 1 psychopharmacology
course. In addition, he is on the faculty at the University of Siena School of Medicine
in Siena, Italy. He received his medical training at the University of Pisa School
of Medicine, Pisa, Italy, and completed his psychiatric residency at the University
of Modena Medical School, Modena, Italy.
Professor Fagiolini has published several books chapters and has authored or coauthored
approximately 70 articles in major peer-reviewed medical journals, including the
American Journal of Psychiatry, Journal of Clinical Psychiatry, CNS Drugs, and Archives
of General Psychiatry. His research interests and publications have primarily focused
on bipolar and major depressive disorders. He has studied pharmacologic treatment
of mood disorders, suicidality, functional impairment, and quality of life in patients
with bipolar disease, as well as the relationship between bipolar disorder and medical
conditions such as obesity and other metabolic disturbances.
|